(Q34654001)

English

Phase II trial of copper depletion with tetrathiomolybdate as an antiangiogenesis strategy in patients with hormone-refractory prostate cancer.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17641535%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

Phase II trial of copper depletion with tetrathiomolybdate as an antiangiogenesis strategy in patients with hormone-refractory prostate cancer (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17641535%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

phase II clinical trial

0 references

0 references

prostate cancer

1 reference

based on heuristic

inferred from title

Kenneth J. Pienta

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17641535%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17641535%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

author name string

N Lynn Henry

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17641535%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

Rodney Dunn

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17641535%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

Sofia Merjaver

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17641535%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

Quintin Pan

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17641535%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

George Brewer

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17641535%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

publication date

1 January 2006

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17641535%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17641535%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

71

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17641535%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

3-4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17641535%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

168-175

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17641535%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

Randomized phase II trial of docetaxel plus thalidomide in androgen-independent prostate cancer

1 reference

https://api.crossref.org/works/10.1159%2F000106066

21 January 2018

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34654001&oldid=1980152532"